Skip to main content
Two phase I dose-escalation/pharmacokinetics studies of low temperature liposomal doxorubicin (LTLD) and mild local hyperthermia in heavily pretreated patients with local regionally recurrent breast cancer.
Published Web Location
http://europepmc.org/articles/PMC4162656?pdf=renderNo data is associated with this publication.
Abstract
Unresectable chest wall recurrences of breast cancer (CWR) in heavily pretreated patients are especially difficult to treat. We hypothesised that thermally enhanced drug delivery using low temperature liposomal doxorubicin (LTLD), given with mild local hyp
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.